Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2009, p. 319-322, Vol. 53, No. 1
0066-4804/09/$08.00+0 doi:10.1128/AAC.00595-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

Division of Anaerobe Research, Life Science Research Center, Gifu University, 1-1 Yanagido, Gifu 501-1194, Japan,1 Department of Infection Control and Prevention, Aichi Medical University, 21 Karimata, Yazako, Nagakute-cho, Aichi-gun, Aichi 480-1195, Japan2
Received 7 May 2008/ Returned for modification 7 June 2008/ Accepted 17 October 2008
The antianaerobic activity of tomopenem, a new longer-half-life parenteral carbapenem, was compared with other carbapenems. Tomopenem showed broad activity against 63 reference species. The activity of tomopenem against 293 clinical isolates was potent (MIC90, 0.06 to 4 µg/ml) and comparable to those of meropenem and doripenem and more potent than that of panipenem.
Published ahead of print on 27 October 2008.
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»